Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The US Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

The Drug Allergy History Tool, which relies on patient symptom reporting, has strong reliability when compared with EHR drug allergy information.

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and ...

Eli Lilly says its GLP-1 drug in pill form is as safe and effective as Ozempic and other mega-popular injectable drugs for weight loss and lowering blood sugar. The company announ ...

Eli Lilly, which makes Zepbound and Mounjaro, reports that in a phase one clinical trial, a once daily GLP-1 pill helped lower the hemoglobin A1C, a measure of blood sugar control, in people with type ...

University Hospitals Coventry and Warwickshire Trust is to lead a clinical trial of a novel device aimed at addressing ...

Ligand Pharmaceuticals’ topical skin infection gel Zelsuvmi is changing hands again—sort of.  | The combined company is ...

Layered drug nanoparticles can now be produced efficiently and at scale using a microfluidic method that eliminates ...